Video

Dr. Fowler on Selection Criteria for Surgical Procedures in Ovarian Cancer

Jeffrey M. Fowler, MD, discusses selection criteria that can help determine which surgical procedure to pursue in ovarian cancer.

Jeffrey M. Fowler, MD, professor of gynecologic oncology, The Ohio State University Comprehensive Cancer Center—–James, discusses selection criteria that can help determine which surgical procedure to pursue in ovarian cancer.

Radical tumor debulking procedures such as splenectomy, diaphragm resection, large bowel resection with anastomosis, or dual bowel resections may be considered for fit patients who are likely to achieve no gross residual disease after surgery, says Fowler.

Patients whose tumor is <1 cm should be considered for radical tumor debulking procedures on an individualized basis, explains Fowler.

Notably, a hysterectomy with bilateral salpingo-oophorectomy, peritoneal stripping, or omentectomy with or without lymph node dissection can also be used to resect a patient’s tumor to <1 cm, concludes Fowler.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma
Multimedia

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

May 15th 2025 - May 16th 2026

online-activity
Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer
Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

May 15th 2025 - May 16th 2026

online-activity
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Louisiana

May 14th 2025 - Jun 19th 2025

online-activity